Skip Navigation

Your Environment. Your Health.

Licensing Opportunities

Technology Transfer

The inventions created in NIEHS laboratories may be transferred to the private sector for further research and development, and eventual commercialization through licenses. A company may acquire any of the following licenses:

 

  • Unpatented Material
  • Patented Material
  • Patent-pending Material
  • Commercial Evaluation
  • Biological Materials
  • Exclusive/Nonexclusive

 

NIEHS Technologies Available for License & Collaborative Development

CATEGORY TITLE KITS* CASE NO.
 
Antibody Estrogen Receptor (ER) alpha P2 and P3, ER gamma Polyclonal Abs ES-079
  Rabbit Antibodies to Mouse and Human Lactoferrin and C3 ES-081
  Mouse Monoclonal Antibody to Nitrone Spin Trap 5,5-dimethyl-1-pyrroline N-oxide (DMPO) ES-086
  Monoclonal Antibody to Human DNA Polymerase Beta ES-100
  Polyclonal Antibodies to Ser 134 Phosphorylated form of the Human Glucocorticoid Receptor ES-107
  Mouse Monoclonal Antibodies to Human Tristetraprolin (TTP) ES-112
  Monoclonal Antibodies Inhibitory to Human CYP2J2 ES-116
  Polyclonal Antibodies to Human CYP2J and CYP2C ES-117
  Antibody to pro-peptide of NSAID-activated Gene (NAG-1)/GDF-15 ES-125
 
Cells Chinese Hamster Ovary (CHO) Cells Expressing Retinoid Orphan Receptor (ROR)γ and Luciferase Reporter ES-108
 
Methods & Reagents Transformation Associated Recombination System in Yeast for Specific Cloning of DNAs as Yeast Artificial Chromosomes ES-017
  Rapid, Efficient In Vivo site-Directed Mutagenesis Using Oligonucleotides ES-054
  Mouse Lactoferrin ES-081
  An Efficient and Cost-Effective Assay for Genotyping Mice using Melting Curve Analysis ES-114
  Human CYP2J and CYP2C ES-117
  Purified Human DNA Polymerase G ES-120
  Fluorescent Intracellular Calcium Indicators ES-124
 
Mouse Models Estrogen Receptor (ER)-alpha & ER-beta KO Mice ES-002
  Mouse Model for Early Onset Cataract ES-066
  Mouse Expressing Enhanced Signaling for Bone Morphogenetic Protein (BMP): A Model for Human Disease ES-102
  Knock-In mouse and Embryonic Stem Cells Expressing Leukemia Inhibitory Factor (LIF) ES-109
  Transgenic Mouse Expressing Human Nonsteroidal anti-inflammatory drug-activated Gene  (NAG-1) ES-110
  Retinoid Orphan Receptor (ROR)γ Deficient Mice ES-113
  Mouse Strain with Conditional Deletion of SMAD7 gene ES-115
  Transgenic Mouse with Cre recombinase Expressed in Spermatogenic cells under Regulation of the Hspa2 Gene Promoter ES-118
  Heat-shock Protein  A2 (Hspa2) Knock-out Mouse for Study of Spermatogenesis and Male Infertility ES-119
  GLI-Similar 3 (GLIS3) KO Mice and Mice in which GLIS3 is KO in Selective Tissues ES-121
 
Therapeutics Antagonists of Hyaluronan Signaling for Treatment of Airway inflammation and Hyperresponsiveness ES-126
  Anti-inflammatory Actions of Cytochrome P450 Epoxygenase-Derived Eicosanoids ES-039
  Diagnostics and Therapeutics for Hydrocephalus ES-064
  Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson’s and Alzheimer’s Disease ES-078
  Target for Development of Diagnostics and Therapeutics for Abnormal Hematopoiesis ES-095
  Lrch4 - a Novel Regulator of Inflammation ES-122
  Functional Blockade of Inter-alpha-trypsin Inhibitor to Reduce Ariway Hyperreactivity in Environmental and Chronic Respiratory Diseases ES-123
 

* For description of these technologies please go to the NIH-OTT database or contact the NIEHS-OTT for any additional information.